Global Betaine Market Is Expanding Owing To Increasing Use In The Personal Care Sector And Growing Inclination Towards Consumption Of Sports And Energy Drinks

Betaine Market
Betaine Market 

Overview:

Betaine can be used to treat a number of conditions. The most common use of betaine is to help with reducing the levels of plasma homocysteine, which can raise the risk for heart disease and stroke. Betaine can be taken with other vitamins B6, B12 and folic acid to help lower homocysteine levels in the body.

Another important use is to help with fatty liver conditions, such as alcohol abuse and obesity, which can cause fat to build up in the liver. Betaine helps to cleanse the liver of fatty acids by supporting its detoxification processes and digestive functions. It also works to reduce the amount of triglycerides in the blood, which can cause hardening of the arteries. Betaine can increase the production of glutathione, a powerful antioxidant that helps protect the cells from free radical damage.

Market Dynamics:

Increasing product launches are estimated to augment growth of the global Betaine Market during the forecast period. For instance, the first COSMOS-compliant, wax-based pearlizer Euperlan NL Pearl, was introduced by BASF in December 2022. Euperlan NL Pearl is made from organically produced substances like cocomidopropyl betaine, glycerol oleate, and hydrogenated vegetable oil. Moreover, growing side effects associated with betaine and rising preference towards betaine substitutes are anticipated to restrain growth of the global betaine for market during the forecast period.

Impact of COVID-19:

The pandemic was first reported in 2019 in China, and it was transmitted to other nations. The pandemic hampered the growth of many sectors including aerospace, automobile, electronics, consumer goods, semiconductors and many more. The pandemic had the most adverse impact on the healthcare sector.

As the number of COVID-19 cases were increasing globally, hospitals worldwide were running on full capacity. There was a shortage of drugs, medical supplies and other resources. To overcome this, many pharmaceutical companies were focusing on developing drugs for COVID-19. This hampered the growth and demand for betaine. Thus, the pandemic had a negative impact on the growth of the global Betaine Market.

Key Takeaways:

The global Betaine Market is expected to witness robust growth, exhibiting CAGR of 4.43 % over the forecast period, due to rising acquisitions by key players.

For instance, Hinduja Global Solutions' healthcare business process outsourcing (BPO) services were acquired by Betaine. In 2021, this acquisition was approved by the Competition Commission of India.

North America is anticipated to witness robust growth in the global market for betaine during the forecast period, due to growing demand for bio-based products for home care and personal care applications.

Key players active in the global Betaine Market are Prasol Chemicals Limited, DuPont, Orison Chemicals Limited, AMINO GmbH, Fengchen Group Co.,Ltd, BASF SE, Evonik Industries AG, Kao Corporation, Merck KGaA, Stepan Company, Nutreco N.V, Solvay, The Lubrizol Corporation, Sunwin Biotech Shandong Co., Ltd.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more